Free_articles - Articles | CARLAT PUBLISHING

An Off-Label Guide to Gabapentin

January 31, 2022

Rajesh R. Tampi, MD, MS, DFAPA. and Chris Aiken, MD.

Rajesh R. Tampi, MD, MS, DFAPA. Professor of Medicine, Case Western Reserve University. Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, and Chief of Geriatric Psychiatry, Cleveland Clinic. Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).

Tarasoff: Making Sense of the Duty to Warn or Protect

January 7, 2022

Ahmad Adi, MD, MPH.

Ahmad Adi, MD, MPH. Senior Instructor, Department of Psychiatry, University of Colorado, Anschutz Medical Campu

Hendrick, MD.Editor-in-Chief of the Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Dr. Adi and Dr. Hendrick have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Do we have a duty to warn, or a duty to protect? And what’s the difference?

Principles of Verbal De-Escalation

January 7, 2022

Janet Richmond, MSW.

Victoria Hendrick, MD. Editor-in-Chief of the Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Janet Richmond, MSW. Clinician at VA Boston Healthcare System and McLean Hospital, MA. Associate Clinical Professor of Psychiatry, Tufts University School of Medicine.

Dr. Hendrick and Ms. Richmond have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Simple strategies can be surprisingly effective in verbally de-escalating agitated patients.

Welcoming Our New Editor-in-Chief

January 1, 2022

It’s our pleasure to introduce Dr. Stephanie Collier, MD, MPH, as the editor-in-chief of CGPR. Dr. Collier is the director of education in the Division of Geriatric Psychiatry at McLean Hospital and an instructor in psychiatry at Harvard Medical School.

Introducing The Carlat Geriatric Psychiatry Report

January 1, 2022

Welcome to the inaugural issue of The Carlat Geriatric Psychiatry Report—our fifth CME newsletter. You’ve been asking for a source of unbiased reporting on geriatric psychiatry, and we’ve finally created one. We hope you’ll find it useful.

How to Distinguish the Dementias

January 1, 2022

Jose Ribas Roca, MD. Assistant Professor, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX. Dr. Roca has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There are several types of dementia, and each has a different prognosis and treatment course. This article outlines Dr. Roca's approach for distinguishing between the most common varieties—Alzheimer’s, vascular, Lewy body, and frontotemporal. In addition, the article covers how to differentiate between mild and major neurocognitive disorder (NCD).

CLINICAL UPDATE

Using Equine-Assisted Psychotherapy

October 18, 2021

Anja Kriegeskotten, MD, Peter Parry, MBBS, and Renee Sievert, RN, MFT,

Anja Kriegeskotten, MD Psychiatrist in Australia, accredited equine therapist. Peter Parry, MBBS, consultant child and adolescent psychiatrist and senior lecturer at Flinders University in Adelaide, Australia. Renee Sievert, RN, MFT, certified equine therapist, CA. Dr. Kriegeskotten, Dr. Parry, and Ms. Sievert have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Equine therapy is becoming popular for a variety of child and adolescent mental health problems, from ADHD, anxiety disorders and PTSD to developmental challenges. In this article our experts describe the nuts and bolts of equine assisted psychotherapy, covering the research and the practicalities of these approaches.

ECT Worked: Now What?

August 3, 2021

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Your patient has recovered from depression with ECT, but their chances of going back into it are high (80%). In this article, learn 3 ways to reduce that risk.

Lemborexant and Sleep Architecture in the Elderly

August 3, 2021

Garrett Rossi, MD.

Garrett Rossi, MD. Dr. Rossi has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It’s rare to see a hypnotic that improves sleep architecture, not to mention next-day functioning. Lemborexant hopes to change that.

Comparison of GI Side Effects of Antidepressants

August 3, 2021

Jesus Ligot, MD.

Jesus Ligot, MD. Dr. Ligot has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Modern antidepressants are ranked by their risk of GI side effects, with a few surprises baked in.